Back to Search Start Over

The H3K36me2 writer-reader dependency in H3K27M-DIPG.

Authors :
Yu JR
LeRoy G
Bready D
Frenster JD
Saldaña-Meyer R
Jin Y
Descostes N
Stafford JM
Placantonakis DG
Reinberg D
Source :
Science advances [Sci Adv] 2021 Jul 14; Vol. 7 (29). Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
Publication Year :
2021

Abstract

Histone H3K27M is a driving mutation in diffuse intrinsic pontine glioma (DIPG), a deadly pediatric brain tumor. H3K27M reshapes the epigenome through a global inhibition of PRC2 catalytic activity and displacement of H3K27me2/3, promoting oncogenesis of DIPG. As a consequence, a histone modification H3K36me2, antagonistic to H3K27me2/3, is aberrantly elevated. Here, we investigate the role of H3K36me2 in H3K27M-DIPG by tackling its upstream catalyzing enzymes (writers) and downstream binding factors (readers). We determine that NSD1 and NSD2 are the key writers for H3K36me2. Loss of NSD1/2 in H3K27M-DIPG impedes cellular proliferation and tumorigenesis by disrupting tumor-promoting transcriptional programs. Further, we demonstrate that LEDGF and HDGF2 are the main readers mediating the protumorigenic effects downstream of NSD1/2-H3K36me2. Treatment with a chemically modified peptide mimicking endogenous H3K36me2 dislodges LEDGF/HDGF2 from chromatin and specifically inhibits the proliferation of H3K27M-DIPG. Our results indicate a functional pathway of NSD1/2-H3K36me2-LEDGF/HDGF2 as an acquired dependency in H3K27M-DIPG.<br /> (Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)

Details

Language :
English
ISSN :
2375-2548
Volume :
7
Issue :
29
Database :
MEDLINE
Journal :
Science advances
Publication Type :
Academic Journal
Accession number :
34261657
Full Text :
https://doi.org/10.1126/sciadv.abg7444